Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2013


3rd Annual Pre-Filled Syringes Summit

24 Sep 2013 - 26 Sep 2013 - Washington DC, USA



Bookmark and Share


Get clarity on regulations and learn to develop safer, more robust pre-filled syringes…
The market for pre-filled syringes continues to grow healthily, but why is the field still held back by the same issues year after year? Component quality still isn’t consistent; package integrity is still proving tough to test robustly enough. Regulations on human factors and combination products are as unclear as ever.

The 3rd Annual Pre-Filled Syringes Summit, will bring together leaders from all areas of pre-filled syringe development, manufacturing and regulation. Together we will share and discuss ideas to help overcome the problems holding back progress. So join us to help uncover and develop practical, near term, solutions to solve themNOW.

With an agenda put together with the help of thought leaders from the FDA,Genentech, Pfizer, Amgen, Eli Lilly, Baxter, Sanofi, Novartis, Janssen,Hospira, GlaxoSmithKline and many more, the 3rd Annual Pre-filled Syringes Summit will dig deeper than any other meeting. You will leave with immediately actionable solutions to help get your pre-filled syringe projects moving in the right direction. Whether you need clarity on regulations, or want an opportunity to network and discuss the problems you currently face, The 3rd Annual Pre-Filled Syringes Summit is the only North American meeting this year that can truly deliver.


Further information
Scientific News
First New HIV Vaccine Study for Seven Years Begins
South Africa hosts historic clinical trial of experimental HIV vaccine aiming to safely prevent HIV infection.
Vaccination Against UTIs
Researchers have successfully vaccinated mice against E.coli growth in the bladder and kidneys.
First Steps to Neutralising Zika
Researchers have discovered a highly potent antibody that neutralises Zika infection at a cellular level.
Human Astrovirus Structure Could Lead to Therapies, Vaccines
Study shows where neutralizing antibody binds to human astrovirus, a leading cause of viral diarrhoea in children, elderly, and the immune-compromised.
Fighting Off HIV Infection Closer to Reality
Researchers have made significant progress in the development of a potential vaccine to protect against HIV infection.
Powerful New Tools to Combat Zika
Researchers have created a way to replicate the stucture of Zika virus, removing the genes that make the virus infectious.
More Immunotherapy Options Approved for Lung Cancer
The FDA has approved a new immunotherapy drug for certain patients with non-small cell lung cancer.
Dissecting Bacterial Infections at the Single-Cell Level
Researchers have used single-cell analysis technology to provide new insight into the Salmonella infection process.
Injectable Biologic Therapy Reduces Triglycerides
Study finds first-of-its-kind therapy promising for patients with high triglycerides, cholesterol.
DNA-Based Zika Vaccine Showed Protection From Infection, Brain Damage and Death
The study is the first of its kind to analyze a vaccine in an animal model that is susceptible to the disease, providing information regarding the protective impact of the immune response in susceptible individuals.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!